FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to fluorouracil
Related studies linked through entity extraction aliases.
Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection
- Status
- UNKNOWN
- Phase
- PHASE3
Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
- Status
- SUSPENDED
- Phase
- PHASE4
Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study
- Status
- TERMINATED
- Phase
- PHASE2
C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2